High Annexin A5 expression promotes tumor progression and poor prognosis in renal cell carcinoma.

Tang, Jingyuan; Qin, Zhiqiang; Han, Peng; Wang, Wei; Yang, Chengdi; Xu, Zhen; Li, Ran; Liu, Bianjiang; Qin, Chao; Wang, Zengjun; Tang, Min; Zhang, Wei

Tang, Jingyuan; Qin, Zhiqiang; Han, Peng; Wang, Wei; Yang, Chengdi; Xu, Zhen; Li, Ran; Liu, Bianjiang; Qin, Chao; Wang, Zengjun; Tang, Min; Zhang, Wei.

Afiliação

Tang J; Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210009, P.R. China.
Qin Z; Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210009, P.R. China.
Han P; Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210009, P.R. China.
Wang W; Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210009, P.R. China.
Yang C; Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210009, P.R. China.
Xu Z; Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210009, P.R. China.
Li R; Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210009, P.R. China.
Liu B; Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210009, P.R. China.
Qin C; Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210009, P.R. China.
Wang Z; Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210009, P.R. China.
Tang M; Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210009, P.R. China.
Zhang W; Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210009, P.R. China.

Int J Oncol ; 50(5): 1839-1847, 2017 May.

Article em En | MEDLINE | ID: mdl-28393205

Assuntos

Anexina A5/biossíntese; Biomarcadores Tumorais/biossíntese; Carcinoma de Células Renais/genética; Transformação Celular Neoplásica/genética; Metaloproteinase 2 da Matriz/genética; Metaloproteinase 9 da Matriz/genética; Animais; Anexina A5/genética; Biomarcadores Tumorais/genética; Carcinoma de Células Renais/patologia; Linhagem Celular Tumoral; Proliferação de Células/genética; Progressão da Doença; Transição Epitelial-Mesenquimal/genética; Regulação Neoplásica da Expressão Gênica; Humanos; Camundongos; Proteína Oncogênica v-akt/genética; Fosfatidilinositol 3-Quinases/genética; Prognóstico; Transdução de Sinais; Serina-Treonina Quinases TOR/genética; Ensaios Antitumorais Modelo de Xenoenxerto

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Biomarcadores Tumorais / Transformação Celular Neoplásica / Anexina A5 / Metaloproteinase 2 da Matriz / Metaloproteinase 9 da Matriz Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google